(SAN CLEMENTE, Calif., January 26, 2010) A new clinical trial investigating the health benefits of aa, the antioxidant and vitamin-rich berry, is adding to the emerging scientific evidence of the fruits ability to potentially reduce some metabolic risk factors associated with cardiovascular disease, diabetes and stroke. The latest study won top honors during the Scripps Center for Integrative Medicine on January 23 and revealed promising initial results for using Sambazon aa to improve vascular health, lower fasting blood sugar levels, and lower bad cholesterol.
This pilot study demonstrated the ability of the Sambazon aa pulp product to significantly lower several markers of cardiovascular risk in a relatively short period of time. Given these promising results, and the biologically active components in the aa fruit, further study is merited, said Dr. Jay Udani, MD, CEO and Medical Director of Medicus Research, a leading contract research organization with functional food experience.
Medicus Research recently conducted a pilot study with 10 slightly overweight, but healthy adult male and female participants (representing 1/3 of the American population). Each study participant consumed 100 grams of Sambazon aa frozen fruit pulp twice daily for one month. Researchers measured participants baseline fasting plasma glucose, plasma insulin levels, lipid levels (total cholesterol, HDL, LDL, triglycerides), high sensitivity C-reactive protein and blood pressure. After 30 days of consuming Sambazon aa, participants fasting glucose, insulin, total cholesterol, and LDL (bad cholesterol) were significantly reduced, as compared to the baseline. In addition, post-prandial (between meals) increases in blood glucose levels were significantly reduced.
While additional research is needed, this pilot study suggests that in otherwise healthy, overweight adults, daily consumption of Sambazon aa reduces several markers of metabolic syndrome associated with an increased risk of diabetes, cardiovascular disease, and stroke, said Jack F. Bukowski, MD, Ph.D., a former Harvard professor and currently Director of the Nutritional Science Research Institute.
This study follows a recently published study showing that aa consumption lowers cholesterol and raises antioxidant activity in rats. Sambazon is committed to scientific and nutritional research about aa and supported the Medicus clinical trial. Sambazon Aa Pure Pulp Packs, which were used in the Medicus study, are a top selling frozen fruit item and available in finer grocery and natural food stores.
Source: Sambazon
